GIVAX, Inc.

GIVAX, Inc. is a biotech company that is backed by RA Ventures, the venture-focused arm of RA Capital Management, LP. GIVAX is developing novel oral vaccines to eliminate the burden of preventable GI disease in children & adults. Our lead program is a dual pediatric rotavirus / norovirus vaccine.